Special notice
Intent to Sole Source - Untargeted Metabolomics Analysis
NOI-OLAO-CC-26-008751
National Institutes of Health, National Institutes of Health. Testing Laboratories and Services.
Response deadline
August 31, 2026 at 12:00 PM EDT
Closed 62 days ago. Posted August 21, 2026. Scheduled to archive September 15, 2026.
Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities
This one closed in 2026
23 like it are open now in testing laboratories and services
- Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance
National Institutes of Health, National Institutes of Health Olao
PresolicitationNAICS 541380Bethesda, MD75N98027Q00040Closes in 8 daysNov 9 - VACCHCS Pharmacy Certification
Department of Veterans Affairs, 261-Network Contract Office 21
Combined synopsis and solicitationNAICS 541380Fresno, CA36C26127Q0099Closes tomorrowNov 2 - Troubleshooting, Calibration and as-needed Remedial Repair of Proof Test Machines
Department of the Navy, Pearl Harbor Naval Shipyard Imf
SolicitationSmall businessNAICS 541380HawaiiN32253-27-Q-0001Closes tomorrowNov 2
Description
As published on SAM.gov.
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Metabolon, Inc.
Acquisition Description:
The TBHP Branch (TBHP) requests the purchase of a contract for Metabolon, Inc., to perform untargeted metabolomics analysis of human fecal samples. The materials will be used in a collaborative protocol between the NIH Clinical Center TBHP Branch, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung, and Blood Institute to quantify and compare microbiome-derived metabolites and dietary xenobiotics in diets primarily consisting of unprocessed and ultra-processed food to investigate metabolic pathways altered by ultra-processed diets.
The metabolomics analysis needs to be able to:
- Detect and quantify a broad panel of small-molecule metabolites (including dietary xenobiotics and microbiota-derived compounds) in fecal samples
- Enable simultaneous analysis of a large array of cytokines, chemokines, and metabolites in small sample volumes
- Interface with Thermo Fisher Scientific Luminex platforms for downstream immune/metabolic biomarker analysis
- Provide comprehensive untargeted metabolite coverage validated for use with human fecal samples.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-008751) by 12:00 PM eastern standard time on 08/31/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Metabolon untargeted metabolomics analysis sole source memo_2026_07_26.docx48 KB, August 21, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 21, 2026
Special notice
Due August 31, 2026 at 12:00 PM EDT. SAM.gov, notice 916aa510d7ce4aa38655622f4aae2308
1 revisions on SAM
- August 21, 2026: publish, special notice